Linked Data API

Show Search Form

Search Results

1649525
registered interest false more like this
date less than 2023-07-03more like thismore than 2023-07-03
answering body
Department for Culture, Media and Sport more like this
answering dept id 217 more like this
answering dept short name Culture, Media and Sport more like this
answering dept sort name Culture, Media and Sport more like this
hansard heading Historic England: Public Appointments more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government when they expect to announce who will be appointed as the new Chair of Historic England. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL9003 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-07-11more like thismore than 2023-07-11
answer text <p>The process to appoint a new Chairman of Historic England is ongoing. An appointment will be made and announced in due course, in line with the Governance Code for Public Appointments.</p> more like this
answering member printed Lord Parkinson of Whitley Bay more like this
question first answered
less than 2023-07-11T11:28:19.043Zmore like thismore than 2023-07-11T11:28:19.043Z
answering member
4728
label Biography information for Lord Parkinson of Whitley Bay more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1457047
registered interest false more like this
date less than 2022-04-07more like thismore than 2022-04-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Prescription Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how many drugs which have received regulatory approval since January 2019 are only available through the NHS and cannot be prescribed by private physicians. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7825 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-04-22more like thismore than 2022-04-22
answer text <p>All authorised medicines and vaccines regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) can be prescribed by a prescribing clinician as a private prescription. However, the decision to place a medicine or vaccine on the private market is a matter for the individual manufacturer. Information on drugs which have received the MHRA’s approval and solely available through the National Health Service is not held centrally.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-04-22T09:17:43.673Zmore like thismore than 2022-04-22T09:17:43.673Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1457048
registered interest false more like this
date less than 2022-04-07more like thismore than 2022-04-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Prescription Drugs: Coronavirus more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what contractual arrangements they have, if any, with pharmaceutical companies that prevent the sale of antiviral drugs for COVID-19 by private clinicians. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7826 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-04-20more like thismore than 2022-04-20
answer text <p>The pharmaceutical companies producing antivirals have not made these treatments commercially available to the private health care sector in the United Kingdom. These products have been procured by the Department and are only available through the National Health Service.</p><p>The Department has agreed contracts with MSD and Pfizer to ensure that the UK has sufficient antiviral medication to treat those who are likely to benefit. There is no legislation which sets out the patient cohorts to receive antiviral treatments for COVID-19. Clinically eligible cohorts have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the UK Chief Medical Officers.</p> more like this
answering member printed Lord Kamall more like this
grouped question UIN HL7827 more like this
question first answered
less than 2022-04-20T11:31:24.84Zmore like thismore than 2022-04-20T11:31:24.84Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1457049
registered interest false more like this
date less than 2022-04-07more like thismore than 2022-04-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Prescription Drugs: Coronavirus more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what legislation requires Public Health England to provide antiviral treatments for COVID-19 to only those people with particular health conditions. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7827 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-04-20more like thismore than 2022-04-20
answer text <p>The pharmaceutical companies producing antivirals have not made these treatments commercially available to the private health care sector in the United Kingdom. These products have been procured by the Department and are only available through the National Health Service.</p><p>The Department has agreed contracts with MSD and Pfizer to ensure that the UK has sufficient antiviral medication to treat those who are likely to benefit. There is no legislation which sets out the patient cohorts to receive antiviral treatments for COVID-19. Clinically eligible cohorts have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the UK Chief Medical Officers.</p> more like this
answering member printed Lord Kamall more like this
grouped question UIN HL7826 more like this
question first answered
less than 2022-04-20T11:31:24.9Zmore like thismore than 2022-04-20T11:31:24.9Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1455661
registered interest false more like this
date less than 2022-03-29more like thismore than 2022-03-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Prescription Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what assessment they have made of (1) the use of (a) molnupiravir, and (b) Paxlovid, as antiviral treatments for COVID-19 in other countries, and (2) the rules for administering such treatments, when considering how to administer and distribute those treatments in England. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7452 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-04-04more like thismore than 2022-04-04
answer text <p>Molnupiravir and nirmatrelvir + ritonavir (co-packaged as Paxlovid) are available for the treatment of COVID-19 in multiple countries. The Antivirals and Therapeutics Taskforce is engaging with international organisations and nations to share learning on the use and deployment of therapeutics and antivirals, including molnupiravir and Paxlovid.</p><p>Eligibility for oral antivirals has been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the United Kingdom Chief Medical Officers. This policy is based on evidence that individuals with specific health conditions are more likely to progress to severe disease. In the community, eligible patients have access to oral antivirals through COVID Medicines Delivery Units in England, with equivalent arrangements in Scotland, Wales and Northern Ireland. In addition, Paxlovid is available to eligible patients who contract COVID-19 whilst in hospital. We are continuing to monitor international use and administration of these treatments to inform the clinical policy.</p>
answering member printed Lord Kamall more like this
question first answered
less than 2022-04-04T16:30:33.53Zmore like thismore than 2022-04-04T16:30:33.53Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1455690
registered interest false more like this
date less than 2022-03-29more like thismore than 2022-03-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Prescription Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 28 March (HL7225), why decisions on the deployment of antiviral treatments for COVID-19 for people beyond the highest risk groups are tied to the outcomes of the PANORAMIC study; and when they expect such decisions to be made. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7453 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-04-04more like thismore than 2022-04-04
answer text <p>We are ensuring that deployment of antiviral treatments is supported by comprehensive data on clinical and cost-effectiveness to ensure healthcare professionals and patients have full confidence in prescribing and receiving these treatments.</p><p>The PANORAMIC study was established following a recommendation from an expert clinical panel. The expert panel advised that additional information should be gathered on which patients would benefit most from antiviral treatments in the United Kingdom, given high rates of vaccination. Previous trials have predominantly used unvaccinated participants.</p><p>Results for the first antiviral treatment, molnupiravir, are likely to be available in summer 2022, when a decision on clinical access will be made by an expert panel. The second antiviral treatment, Paxlovid, is expected to enter the PANORAMIC study in April 2022.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-04-04T16:22:05.337Zmore like thismore than 2022-04-04T16:22:05.337Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1454242
registered interest false more like this
date less than 2022-03-24more like thismore than 2022-03-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Prescription Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 24 March (HL7023), why antiviral treatments for COVID-19 are not commercially available; and what assessment they have made of the effectiveness of such treatments. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7338 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-04-04more like thismore than 2022-04-04
answer text <p>The pharmaceutical companies producing antivirals have not made these treatments commercially available to the private health care sector in the United Kingdom. The supply of the COVID-19 oral antiviral treatments approved by the Medicines and Healthcare products Regulatory Agency is commercially available to the Government for National Health Service patients and the devolved administrations. Pharmaceutical companies are responsible for the commercial decisions on the availability of their products.</p><p>The Merk Sharp and Dohme clinical trial of molnupiravir showed that the drug reduces the relative risk of hospitalisation or death by 30%. Pfizer’s trial of nirmatrelvir+ritonavir showed an 89% reduction in hospitalisation or death compared to a placebo. The PANORAMIC national study will inform our understanding on how oral antiviral treatments perform in the UK, where the majority of the population is vaccinated. This will inform future decisions on access for patients in the UK.</p>
answering member printed Lord Kamall more like this
question first answered
less than 2022-04-04T16:18:13.79Zmore like thismore than 2022-04-04T16:18:13.79Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1454243
registered interest false more like this
date less than 2022-03-24more like thismore than 2022-03-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Medical Treatments more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how many COVID-19 patients are currently in hospital; whether those patients are being given antiviral treatments to aid their recovery; and if so, what is the average length of time it takes patients receiving such treatments to be cured. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7339 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-03-30more like thismore than 2022-03-30
answer text <p>As of 28 March 2022, the number of patients currently in hospital with COVID-19 is 17,685. A range of treatments are available to these patients, including antivirals. Eligible patients admitted to hospital for reasons not related to COVID-19 and subsequently test positive are able to access nirmatrelvir + ritonavir (Paxlovid), an oral antiviral treatment or remdesivir, an intravenous antiviral. For patients whose immune system means they are at higher risk of COVID-19, the antiviral treatments molnupiravir, nirmatrelvir + ritonavir and remdesivir are available in the community to reduce the risk of hospitalisation and death.</p><p> </p><p>Approximately 120,000 treatments have been provided in England, of which 53,000 were antivirals administered to hospitalised patients. The data requested on the average time for patients receiving antivirals to be cured is not held centrally.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-03-30T11:00:09.393Zmore like thismore than 2022-03-30T11:00:09.393Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1454244
registered interest false more like this
date less than 2022-03-24more like thismore than 2022-03-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Prescription Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 24 March (HL7023), why they are retaining stocks of COVID-19 antiviral treatments. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7340 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-03-30more like thismore than 2022-03-30
answer text <p>The Government has secured 4.98 million patient courses of oral antiviral treatments. As a result, there are supplies of oral antivirals molnupiravir and nirmatrelvir+ritonavir held in the United Kingdom with regular deliveries to ensure sufficient treatment for patients. These are available to eligible patients in the community at highest risk of developing severe disease through COVID Medicines Delivery Units in England and equivalent arrangements in Scotland, Wales and Northern Ireland. In addition, nirmatrelvir + ritonavir is available to eligible patients who contract COVID-19 whilst in hospital.</p><p>We continue to monitor clinical trial results to understand which patient cohorts may benefit from oral antivirals, including the PANORAMIC national study. The results will inform our understanding of the performance of oral antivirals where the majority of the population is vaccinated and future decisions on patient access in the UK.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-03-30T11:00:36.997Zmore like thismore than 2022-03-30T11:00:36.997Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this
1453452
registered interest false more like this
date less than 2022-03-22more like thismore than 2022-03-22
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Prescription Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 21 March (HL6991), what body was responsible for the decision that antiviral treatments for COVID-19 can only be prescribed by a clinician within a COVID Medicine Delivery Unit and are not available for general practice prescribing and purchase directly from pharmacies; when this decision was taken, and why. more like this
tabling member printed
Baroness Rawlings remove filter
uin HL7225 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-03-28more like thismore than 2022-03-28
answer text <p>The decision was made by NHS England and NHS Improvement prior to December 2021, when the first COVID Medicine Delivery Units were launched. Any decisions on the longer-term deployment of COVID-19 treatments beyond the highest risk groups will be subject to the outcomes of the PANORAMIC study on the effectiveness of antivirals in the United Kingdom population.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-03-28T16:24:59.703Zmore like thismore than 2022-03-28T16:24:59.703Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
3278
label Biography information for Baroness Rawlings more like this